TY - JOUR AU - Todaka, K. AU - Wang, J. AU - Yi, G. H. AU - Stennett, R. AU - Knecht, M. AU - Packer, M. AU - Burkhoff, D. PY - 1996 DA - 1996// TI - Effects of levosimendan on myocardial contractility and oxygen consumption JO - J Pharmacol Exp Ther VL - 279 ID - Todaka1996 ER - TY - JOUR AU - Levijoki, J. AU - Pollesello, P. AU - Kaivola, J. AU - Tilgmann, C. AU - Sorsa, T. AU - Annila, A. AU - Kilpelainen, I. AU - Haikala, H. PY - 2000 DA - 2000// TI - Further evidence for the cardiac troponin C mediated calcium sensitization by levosimendan: structure-response and binding analysis with analogs of levosimendan JO - J Mol Cell Cardiol VL - 32 UR - https://doi.org/10.1006/jmcc.1999.1093 DO - 10.1006/jmcc.1999.1093 ID - Levijoki2000 ER - TY - STD TI - Simdax - Levosimendan 2.5 mg/mL injection concentrate - Data Sheet. 2009, New Zealand, New Zealand Medicines and Medical Devices Safety Authority, a Business Unit of the Ministry of Health, 1-10-2010., [http://www.medsafe.govt.nz/profs/Datasheet/s/Simdaxinj.htm] UR - http://www.medsafe.govt.nz/profs/Datasheet/s/Simdaxinj.htm ID - ref3 ER - TY - JOUR AU - Mebazaa, A. AU - Nieminen, M. S. AU - Packer, M. AU - Cohen-Solal, A. AU - Kleber, F. X. AU - Pocock, S. J. AU - Thakkar, R. AU - Padley, R. J. AU - Poder, P. AU - Kivikko, M. PY - 2007 DA - 2007// TI - Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial JO - JAMA VL - 297 UR - https://doi.org/10.1001/jama.297.17.1883 DO - 10.1001/jama.297.17.1883 ID - Mebazaa2007 ER - TY - JOUR AU - Bowman, P. AU - Haikala, H. AU - Paul, R. J. PY - 1999 DA - 1999// TI - Levosimendan, a calcium sensitizer in cardiac muscle, induces relaxation in coronary smooth muscle through calcium desensitization JO - J Pharmacol Exp Ther VL - 288 ID - Bowman1999 ER - TY - JOUR AU - Keheninen, P. AU - Haikala, H. PY - 1998 DA - 1998// TI - Increases in diastolic coronary flow by Levosimendan and pinacidil are differently mediated through opening of the ATP-sensitive potassium channels JO - J Amer Coll Cardiol VL - 31 UR - https://doi.org/10.1016/S0735-1097(97)84373-2 DO - 10.1016/S0735-1097(97)84373-2 ID - Keheninen1998 ER - TY - JOUR AU - Pataricza, J. AU - Hohn, J. AU - Petri, A. AU - Balogh, A. AU - Papp, J. G. PY - 2000 DA - 2000// TI - Comparison of the vasorelaxing effect of cromakalim and the new inodilator, levosimendan, in human isolated portal vein JO - J Pharm Pharmacol VL - 52 UR - https://doi.org/10.1211/0022357001773715 DO - 10.1211/0022357001773715 ID - Pataricza2000 ER - TY - JOUR AU - Yokoshiki, H. AU - Katsube, Y. AU - Sunagawa, M. AU - Sperelakis, N. PY - 1997 DA - 1997// TI - The novel calcium sensitizer levosimendan activates the ATP-sensitive K+ channel in rat ventricular cells JO - J Pharmacol Exp Ther VL - 283 ID - Yokoshiki1997 ER - TY - JOUR AU - Kivikko, M. AU - Lehtonen, L. PY - 2005 DA - 2005// TI - Levosimendan: a new inodilatory drug for the treatment of decompensated heart failure JO - Curr Pharm Des VL - 11 UR - https://doi.org/10.2174/1381612053382043 DO - 10.2174/1381612053382043 ID - Kivikko2005 ER - TY - JOUR AU - Puttonen, J. AU - Kantele, S. AU - Ruck, A. AU - Ramela, M. AU - Hakkinen, S. AU - Kivikko, M. AU - Pentikainen, P. J. PY - 2008 DA - 2008// TI - Pharmacokinetics of intravenous levosimendan and its metabolites in subjects with hepatic impairment JO - J Clin Pharmacol VL - 48 UR - https://doi.org/10.1177/0091270007313390 DO - 10.1177/0091270007313390 ID - Puttonen2008 ER - TY - JOUR AU - Antila, S. AU - Kivikko, M. AU - Lehtonen, L. AU - Eha, J. AU - Heikkila, A. AU - Pohjanjousi, P. AU - Pentikainen, P. J. PY - 2004 DA - 2004// TI - Pharmacokinetics of levosimendan and its circulating metabolites in patients with heart failure after an extended continuous infusion of levosimendan JO - Br J Clin Pharmacol VL - 57 UR - https://doi.org/10.1111/j.1365-2125.2003.02043.x DO - 10.1111/j.1365-2125.2003.02043.x ID - Antila2004 ER - TY - JOUR AU - McLean, A. S. AU - Huang, S. J. AU - Nalos, M. AU - Ting, I. PY - 2005 DA - 2005// TI - Duration of the beneficial effects of levosimendan in decompensated heart failure as measured by echocardiographic indices and B-type natriuretic peptide JO - J Cardiovasc Pharmacol VL - 46 UR - https://doi.org/10.1097/01.fjc.0000189076.71730.f1 DO - 10.1097/01.fjc.0000189076.71730.f1 ID - McLean2005 ER - TY - JOUR AU - Raftopoulos, S. C. PY - 2004 DA - 2004// TI - Levosimendan following coronary artery bypass grafting in a patient with end-stage renal failure: a case report JO - Crit Care Resusc VL - 6 ID - Raftopoulos2004 ER - TY - CHAP AU - Sandell, E. P. AU - Antila, S. AU - Koistinen, I. L. PY - 1995 DA - 1995// TI - The effects of renal failure on the pharmacokinetics of levosimendan [abstract] BT - 1st Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT) ID - Sandell1995 ER - TY - JOUR AU - Antila, S. AU - Honkanen, T. AU - Lehtonen, L. AU - Neuvonen, P. J. PY - 1998 DA - 1998// TI - The CYP3A4 inhibitor intraconazole does not affect the pharmacokinetics of a new calcium-sensitizing drug levosimendan JO - Int J Clin Pharmacol Ther VL - 36 ID - Antila1998 ER - TY - JOUR AU - Haikala, H. AU - Kaivola, J. AU - Nissinen, E. AU - Wall, P. AU - Levijoki, J. AU - Linden, I. B. PY - 1995 DA - 1995// TI - Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan JO - J Mol Cell Cardiol VL - 27 UR - https://doi.org/10.1016/0022-2828(95)90009-8 DO - 10.1016/0022-2828(95)90009-8 ID - Haikala1995 ER - TY - JOUR AU - Lehtonen, L. AU - Mills-Owens, P. AU - Akkila, J. PY - 1995 DA - 1995// TI - Safety of levosimendan and other calcium sensitizers JO - J Cardiovasc Pharmacol VL - 26 UR - https://doi.org/10.1097/00005344-199506261-00010 DO - 10.1097/00005344-199506261-00010 ID - Lehtonen1995 ER -